Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancer

Journal of Medical Economics ◽

10.1080/13696998.2021.1928515 ◽

2021 ◽

pp. 1-1

Author(s):

Ali McBride ◽

Karen MacDonald ◽

Adolfo Fuentes-Alburo ◽

Ivo Abraham

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cost Efficiency ◽

Metastatic Breast ◽

Expanded Access

Download Full-text

PCN49 Biosimilar Trastuzumab Mono- and Pertuzumab Combination Therapy in Metastatic Breast Cancer: Cost Efficiency and Expanded Access Modeling

Value in Health ◽

10.1016/j.jval.2021.04.141 ◽

2021 ◽

Vol 24 ◽

pp. S28

Author(s):

A. McBride ◽

A. Fuentes-Alburo ◽

K. MacDonald ◽

I. Abraham

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Combination Therapy ◽

Cost Efficiency ◽

Metastatic Breast ◽

Expanded Access ◽

Download Full-text

Abstract P1-14-04: Clinical Outcomes of Brain Metastasis by Lapatinib (L) and Capecitabine (C) in an Open-Label Expanded Access Study among Korean Patients with HER2 Positive Metastatic Breast Cancer

10.1158/0008-5472.sabcs10-p1-14-04 ◽

2010 ◽

Author(s):

J Ro ◽

S Park ◽

S-B Kim ◽

T-Y Kim ◽

Y-H Im ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Brain Metastasis ◽

Clinical Outcomes ◽

Metastatic Breast ◽

Her2 Positive ◽

Expanded Access ◽

Korean Patients

Download Full-text

Lapatinib as salvage therapy in metastatic breast cancer: Preliminary results from an expanded access program

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.12006 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 12006-12006

Author(s):

F. Giotta ◽

A. Latorre ◽

G. Monticelli ◽

S. Oliva ◽

D. Albano ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Salvage Therapy ◽

Metastatic Breast ◽

Preliminary Results ◽

Expanded Access ◽

Expanded Access Program ◽

Download Full-text

An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer

Annals of Oncology ◽

10.1093/annonc/mdp373 ◽

2010 ◽

Vol 21 (3) ◽

pp. 474-480 ◽

Author(s):

G. Capri ◽

J. Chang ◽

S.-C. Chen ◽

P. Conte ◽

K. Cwiertka ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Expanded Access

Download Full-text

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer

Cancer Research and Treatment ◽

10.4143/crt.2017.446 ◽

2018 ◽

Vol 50 (4) ◽

pp. 1226-1237 ◽

Author(s):

Renaud Sabatier ◽

Véronique Diéras ◽

Xavier Pivot ◽

Etienne Brain ◽

Henri Roché ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Expanded Access ◽

Expanded Access Program ◽

Microtubules Inhibitors ◽

Download Full-text

A single-institution experience from the Lapatinib Expanded Access Program – effect of lapatinib and capecitabine combination therapy on CNS metastases in patients with ErbB2+ metastatic breast cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(08)70735-3 ◽

2008 ◽

Vol 6 (7) ◽

pp. 175 ◽

Author(s):

B. Kaufman ◽

R. Weitzen ◽

A. Goldfarb ◽

N. Ephrat ◽

I. Kuchuk ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Combination Therapy ◽

Metastatic Breast ◽

Single Institution ◽

Cns Metastases ◽

Expanded Access ◽

Program Effect ◽

Expanded Access Program ◽

Download Full-text

Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2016.03.010 ◽

2016 ◽

Vol 60 ◽

pp. 117-124 ◽

Author(s):

Philippe Aftimos ◽

Laura Polastro ◽

Lieveke Ameye ◽

Christiane Jungels ◽

Jalal Vakili ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Pivotal Phase ◽

Phase Iii Trial ◽

Expanded Access ◽

Expanded Access Program ◽

Download Full-text

Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy — results from an expanded access programme

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)90867-1 ◽

2004 ◽

Vol 2 (3) ◽

pp. 132-133 ◽

Author(s):

L Petruzelka ◽

M Zimovjanova

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Metastatic Breast ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme

Download Full-text

Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience

British Journal of Cancer ◽

10.1038/sj.bjc.6605586 ◽

2010 ◽

Vol 102 (6) ◽

pp. 995-1002 ◽

Author(s):

S Sutherland ◽

S Ashley ◽

D Miles ◽

S Chan ◽

A Wardley ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Brain Metastases ◽

Metastatic Breast ◽

Her2 Positive ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme ◽

Download Full-text

Abstract P3-14-15: Lapatinib Plus Capecitabine in Trastuzumab Pre-Treated HER2- Positive Metastatic Breast Cancer: The Canadian Lapatinib Expanded Access Program Experience

10.1158/0008-5472.sabcs10-p3-14-15 ◽

2010 ◽

Author(s):

J Chang ◽

S Chia ◽

C Prady ◽

K Haider ◽

D Grenier ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Her2 Positive ◽

Expanded Access ◽

Expanded Access Program ◽

Download Full-text